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Abstract 
Cells respond to the mechanical properties of the extracellular matrix (ECM) through formation 
of focal adhesions (FAs), re-organization of the actin cytoskeleton and adjustment of cell 
contractility. These are energy-demanding processes, but a potential causality between 
mechanical cues (matrix stiffness) and cellular (energy) metabolism remains largely unexplored. 
Here, we culture human mesenchymal stem cells (hMSCs) on stiff (20 kPa) or soft (1 kPa) 
substrate and demonstrate that cytoskeletal reorganization and FA formation spreading on stiff 
substrates lead to a drop in intracellular ATP levels, correlates with the activation of 
AMP-activated protein kinase (AMPK). The resulting increase in ATP levels further facilitates 
cell spreading and reinforces cell tension of the steady state, and coincides with nuclear 
localization of YAP/TAZ and Runx2. While on soft substrates (1 kPa), lowered ATP levels limit 
these cellular mechanoresponses. Furthermore, genetic ablation of AMPK lowered cellular ATP 
levels on stiff substrate and strongly reduced responses to substrate stiffness. Together, these 
findings reveal a hitherto unidentified relationship between energy expenditure and the cellular 
mechanoresponse, and point to AMPK as a key mediator of stem cell fate in response to ECM 
mechanics. 
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1. Introduction 
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The physical properties of the extracellular matrix (ECM) have a profound impact on cell behavior 
and stem cell fate, and a direct relationship between matrix stiffness, cell spreading and lineage 
selection has been demonstrated [1, 2, 3, 4, 5, 6]. Forces generated within the actin cytoskeleton 
and transmitted through FAs, play a major role in the cellular response to biophysical cues [7, 8, 9, 
10]. Much attention has been given to how cells respond to mechanical forces. However, less is 
known how these forces are integrated with other cellular processes including bioenergetics [11, 
12, 13]. In order to understand how mechanical forces shape the cellular phenotype and regulate 
cell fate, it is necessary to consider the highly dynamic nature of the cellular response, which 
involves a hitherto overlooked large energy expenditure. Growing evidence indicates that the 
transduction of external mechanical forces is linked to metabolic signals such as neutral lipid 
synthesis [13], mitochondrial structural remodeling [14], cellular glucose uptake [11] and cell 
migration [15]. The cellular response is a well-tuned process that must balance energy supply with 
energy demand to allow proper actin polymerization, FA formation and cellular contractility 
buildup. But it remains unclear how cells respond to this energy expenditure, tune energy supply 
and demand, and maintain energy homeostasis for mechanotransduction. 
AMPK, a well-characterized cellular energy sensor [16], plays a key role in the coordination of 
cell function by controlling intracellular ATP levels [17]. AMPK is Thr172-phosphorylated and 
thereby activated (yielding pAMPK) when the AMP/ATP ratio increases. This occurs for instance 
during starvation, hypoxia or cell detachment from the ECM [18, 19, 20]. Upon AMPK activation, 
energy homeostasis is restored by altering glucose, protein and lipid metabolism, paralleled by 
mitochondrial morphology changes [21]. Mechanical cues, chemical stimulations or metabolic 
stresses [22, 23, 24] can all lead to alterations in mitochondrial morphology, and AMPK is 
considered an important regulator of mitochondrial dynamics through phosphorylation of 
mitochondrial fission factor (Mff), thereby stimulating mitochondrial fission [24, 25]. A recent 
study in MCF10A (human breast epithelial) cells and MDCK II (canine kidney epithelial) cells, 
revealed that external forces from neighboring cells triggered AMPK activation via E-cadherin to 
increase cellular ATP levels and enhance actomyosin contractility, thus linking energy 
homeostasis with cell-cell adhesion mechanotransduction [11]. Actomyosin contractility also 
plays a major role in the cellular response to the physical properties of the ECM through FA 
formation and organization of the actin cytoskeleton, which are ATP-demanding processes [11, 12, 
26].  
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In this study, we aim to elucidate the role of energy expenditure in the cellular response to 
substrate stiffness. When cells were seeded on stiff substrates, we observed an initial drop in ATP 
levels followed by higher ATP levels at 24 hrs, increased glucose uptake and actomyosin 
contractility, altered mitochondrial morphology, and sustained AMPK activation, resulting in 
nuclear localization of YAP/TAZ and Runx2, and osteogenic differentiation. Independent of 
substrate stiffness, cell fate appeared strongly correlated with the activation or inhibition of AMPK. 
Our findings establish a critical role for AMPK in connecting intracellular energy expenditure and 
cellular mechanotransduction, with downstream effects on stem cell fate. 
 
2. Materials and Methods 
Preparation of polyacrylamide (PAAm) hydrogels. This method was adapted from a previously 
described procedure [4, 5]. 13-mm-diameter borosilicate glass coverslips (VWR) were freshly 
oxidized by oxygen plasma and then incubated in a solution composed of 0.3% w/v 
3-(trimethoxysilyl)propyl methacrylate (Sigma Aldrich) and toluene (Fisher Scientific) overnight. 
Slides were washed with ethanol and dried with nitrogen. The stiffness of PAAm gels was 
regulated through the concentration of acrylamide (AA) and bis-acrylamide (BA). PAAm gel 
solutions were prepared with AA at final concentrations of 8, 20 and 30% w/v and BA at 0.02, 0.15 
and 0.375% w/v. 5 µL of 10% w/v ammonium persulfate (Sigma Aldrich) and 1.5 µL TEMED 
(Sigma Aldrich) were added to AA/BA solutions to initiate PAAm polymerization. 4 µL of PAAm 
solution was immediately pipetted onto the pre-treated 13-mm-diamter coverslips and covered 
with an untreated 20-mm-diameter coverslip. The polymerization was completed in about 2 h, and 
then the samples were immersed in PBS buffer overnight. The top coverslips were carefully peeled 
off to obtain the gels adhering to the bottom coverslips. With the different concentrations of 
AA/BA described above, PAAm gels with different stiffness can be prepared. 8% w/v AA and 
0.02% w/v BA, 20% w/v AA and 0.15% w/v BA, 30% w/v AA and 0.375% w/v BA showed 
stiffness of ~ 1 kPa, 20 kPa and 100 kPa, respectively. 
PAAm gels functionalization with collagen I. For cell adhesion, rat tail collagen I (BD 
biosciences) was crosslinked to the PAAm gels using 
N-sulfosuccinimidyl-6-(4′-azido-2′-nitrophenylamino)hexanoate (sulfo-SANPAH, from Life 
Technologies). 30 μL of 1mg/mL sulfo-SANPAH dissolved in milliQ H2O was added to PAAm 
gels which were irradiated under a 365nm UV lamp (ABM, USA) for 5 min. Then, gels were 
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washed twice with PBS and the crosslinking procedure was repeated once more. After that, the 
samples were soaked in 50 μL/mL collagen solution for 2 h at room temperature. Finally, samples 
were washed twice with PBS before cell seeding. 
Cell culture. hMSCs, WT mouse embryonic fibroblasts (MEFs), AMPKα-null MEFs and 
NIH-3T3 mouse fibroblasts were cultured in low glucose DMEM (2 g/L, from Gibco), with 10% 
filtered fetal bovine serum (FBS, from Gibco), 1% penicillin-streptomycin (pen/strep, from 
Thermo) and 1% glutamine (Gibco). hMSCs were obtained from Lonza and cultured to passage 6 
before seeding onto gels at a low density of 1250 per cm2 for studies involving cell spreading, 
mitochondrial dynamics, ATP measurements or specific proteins staining, 5000 per cm2 for 
glucose uptake, 2500 or 25000 per cm2 for osteogenic differentiation on stiff or soft gels, 
respectively, and 25000 per cm2 for adipogenic differentiation. For hMSCs cultured on gels, 
proliferation medium containing high glucose DMEM (4.5 g/L, from Gibco), 10% FBS, 1% 
glutamine and 1% pen/strep was used. For energy starvation, cells were cultured in DMEM 
without glucose, pyruvate or glutamine (Gibco) supplemented with 10 % FBS. For osteogenic or 
adipogenic differentiation, differentiation medium contained of proliferation medium and 
osteogenic/adipogenic chemical supplements (5×10−7 M dexamethasone, 5 mM 
β-glycerolphosphate, 0.1 mM ascorbic acid-2-phosphate, 250 μM 3-isobutyl-1-methylxanthine, 5 
μg/mL insulin, and 5×10−8 M rosiglitazone maleate, all from Sigma). For tests of F-actin inhibition 
(2.5 µM Cytochalasin D, from ChemCruz), myosin inhibition (50 µM Blebbistatin, from 
Calbiochem), Rock inhibition (50 µM Y27632, from Sigma), AMPK inhibition (Compound C, 
from Sigma) or AMPK activation (A-769662, from Cayman Chemical), these chemicals were 
added to the proliferation medium or differentiation medium after 10 - 30 min of cell culture. WT 
MEF and AMPKα-null MEF were gifts from Benoit Viollet (Paris Descartes University), they 
were cultured and tested as described previously [27]. 5000 per cm2 of cells were seeded onto gels 
for all following experiments including ATP measurements, glucose uptake, morphology 
visualization and mechanotransduction markers staining. 
Cell staining. After incubation, cells were fixed with 4% paraformaldehyde (PFA) (Sigma) for 10 
min followed by washing three times with PBS and permeabilized with 0.2% Triton X-100 (Sigma) 
for 10 min at room temperature. For F-actin and G-actin visualization, cells were stained with 
phalloidin-Atto 633 (1:1000, from Sigma), Alexa fluor488–DNaseI (1:500, D12371, from 
Invitrogen), 4', 6-diamidino-2-phenylindole (DAPI) (1:1000, from Millipore) for 1 h. For vinculin, 
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RhoA, β-integrin, myosin, pAMPK, YAP/TAZ and Runx2 staining, nonspecific binding sites 
were blocked in 10% BSA solution for 1 h, followed by incubation with primary antibody 
anti-vinculin (1:500, AB18058, from Abcam), anti-integrin β1 (1:500, AB30394, from Abcam), 
anti-RhoA (1:500, AB187027, from Abcam), anti-myosin IIa (1:500, 150M4764, from Sigma), 
anti-AMPK alpha 1 (phospho T183) + AMPK alpha 2 (phospho T172) (1:500, AB23875, from 
Abcam), anti-YAP/TAZ (1;500, D24E4, from Cell Signaling) and anti-Runx2 (1:500, AB76956, 
from Abcam) for 1 h. Subsequently, stained with DAPI, phalloidin and secondary antibody, 
Alexa-488 goat anti-mouse (1:1000, A11029, from Thermo Fisher Scientific) or anti-rabbit IgG 
(1:1000, A10040, from Thermo Fisher Scientific) for 1 h at room temperature.  
ATP assay. Intracellular ATP levels were measured using ApoSENSOR™ ATP Cell Viability 
Bioluminescence Assay Kit (Biovision), according to the manufacturer’s instructions. Briefly, 
2500 cells were plated onto 13-mm-diameter gels (n≥6 per condition) and cultured to specific time 
points. Cells were lysed with 100 µL of Nuclear Releasing Buffer for 5 min at room temperature 
with gentle shaking. For the ATP levels at the starting time point (0 h), 2500 cells in suspension 
were collected and lysed directly. Then adding 10 µL ATP Monitoring Enzyme to the lysate and 
reading the sample within 2 min in a luminometer (Multimode Microplate Reader, from Berthod). 
The lysed cells were stained with DAPI and imaged with a Leica SP8 confocal microscope. Cell 
number on each gel was calculated from DAPI staining, it was used to normalize the ATP intensity 
to ensure an equal number of cells.  
Glucose uptake. Glucose uptake assays were performed by Glucose Uptake Cell-Based Assay Kit 
(Cayman Chemical) following the manufacturer’s instructions. This kit employs 2-NBDG, a 
fluorescently-tagged glucose derivative, as a probe for the detection of glucose taken up by 
cultured cells. Cells were plated onto 13-mm-diameter gels (n≥6 per condition) and cultured to 20 
h on substrates with different stiffness or with different cell culture medium. Immediately 
following this, cells were treated in glucose-free medium for 2 h. At the end of treatment, 2-NBDG 
was added to a final concentration of 200 µg/mL in glucose-free medium for 30 min incubation. 
For fluorescence images, samples were visualized by Leica SP8 immediately. For uptake intensity 
test, the medium was carefully aspirated without disturbing the cell layer and the Cell-Based Assay 
Buffer was added to cells. After lysing cells, 100 µL of the supernatant was collected to a 96-well 
plate immediately. An additional 50 µL Cell-Based Assay Buffer was added, followed by readout 
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at 485/535nm via microplate reader (Berthold). The number of cells was quantified by DAPI 
staining to normalize the glucose uptake. 
Proliferation assay. EdU labeling, which can incorporate into the DNA of cells during replication, 
was performed for proliferation studies. hMSCs were seeded on gels with different stiffness or 
treated with AMPK inhibitor or activator for 20 h, followed by treatment with EdU solution. When 
the cells were cultured to 48 h, followed by fixed and permeabilized with 4% PFA and 0.1% Triton 
X-100, respectively. Subsequently, samples were treated according to the manufacturer’s protocol 
of Click-iT EdU Alexa Fluor-488 HCS Assay (Thermo Fisher Scientific). Samples were imaged 
by Leica SP8 confocal microscope (Leica, Germany) with 10× objective to collect regions of 
interest. 
Mitochondrial imaging. For time-lapse imaging, hMSCs were cultured on gels with different 
stiffness and placed in a 24 well glass bottom plate (In Vitro Scientific), then mitochondria were 
stained with 100 nM MitoTracker Deep Red (Life Technologies). Up to 30 min incubation, a Leica 
SP8 microscope was used to track the mitochondrial dynamics. Individual images were acquired at 
a 2 min interval with a 20× objective at 37 °C and 7.5% CO2 atmosphere. After acquisition, images 
were analyzed using the Image 5D plugin of Fiji and exported as uncompressed AVI sequences. 
For mitochondrial visualization, 30 min prior to imaging at specific time points after seeding, Mito 
Tracker Deep Red was added to the culture medium. Cells were fixed with 4% PFA, permeabilized 
with 0.2% Triton X-100 and then counterstained with DAPI and phalloidin tetramethyl-rhodamine 
B isothiocyanate (TRITC) (Millipore). Fifteen-image Z-stacks were acquired by SP8 confocal 
with a 63× oil-immersion objective and merged with Fiji software (http://fiji.sc/). 
Mitochondrial membrane potential. The membrane potential was determined by TMRM 
Mitochondrial Membrane Potential Assay Kit (Abcam). Cells were cultured on the gels with 
different stiffness for 20 h, and then adding 100 nM TMRM to the medium 20 min before imaging. 
Live cells were immediately visualized without removing TMRM dye at 37 °C and 7.5% CO2 
atmosphere and images were captured by the 549/575 nm laser of a Leica SP8 confocal 
microscope with a 40× water immersion objective at the photon counting mode.  
Western blotting. Cells were lysed with RIPA buffer (1:10, Cell Signaling) supplemented with 
protease and phosphatase inhibitors (Roche). Protein were collected and quantified using the BCA 
method. Equal amounts of proteins were loaded and separated on 12% Criterion Precast Gel 
(Bio-Rad), subsequently transferred onto PVDF membranes (Bio-Rad) and blocked with 5% 
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non-fat dry milk (Bio-Rad) for 1 h at room temperature. AMPK and pAMPK were stained using 
primary antibody polyclonal AMPK (1:1000, 2532, from cell signaling) and anti-phosphorylated 
AMPK (Thr 172) (1:1000, 2535, Cell Signaling), β-actin (1:2000, from Abcam) was performed as 
loading controls and then incubated overnight on the roller bank at 4 °C. HRP-conjugated 
secondary antibodies, anti-rabbit or anti-mouse immunoglobulins (1:3000, Dako), were applied 
for 1 h at room temperature and detected using SuperSignal chemiluminescent substrates (Pierce). 
Differentiation assay. hMSCs were cultured for 7 or 10 days in mixed medium for osteogenic and 
adipogenic differentiation, respectively. The mixed medium containing the AMPK inhibitor or 
activator was changed twice a week. After incubation up to 7 or 10 days, all samples were fixed 
with 4% PFA and penetrated with 0.2% Triton-X 100 for 10 min, respectively. Osteogenic 
differentiation was analyzed by alkaline phosphatase (ALP) staining with Fast Blue assay 
(naphthol-AS-MSC phosphate and Fast Blue RR, Sigma) in Tris−HCl buffer (pH 8.9) and 
incubating at 37 °C for 1 h. Adipogenic differentiation was analyzed by Oil Red O staining with 
incubating cells with 1.8 mg/mL Oil Red O (Sigma) for 30−60 min at room temperature and then 
washing with 60% isopropanol (Sigma). Finally, nuclei visualization was performed by DAPI and 
images were collected by Zeiss inverted microscope (Photometrics, USA). The quantification of 
osteogenic differentiation was performed by manually counting the number of ALP positive cells 
in relation to the number of DAPI stained cells. 
Microscopy image analysis. Fluorescence images were acquired using a Leica SP8 confocal 
microscope with different objectives and overlaid in Fiji software with Image 5D plugin. All 
analysis of cells was based on single cells not in contact with other cells. For quantification of 
fluorescence intensity, images were taken with photon counting mode to make sure all settings 
were fixed. For quantification of G/F actin ratio, it was performed as our previous studies [28, 29]. 
The integrated fluorescence of F-actin and G-actin z-stack images was measured for individual 
cells, followed by subtraction of the background fluorescence. For quantification of YAP/TAZ 
and Runx2 subcellular localization, nuclear localization was defined as a ratio of the average 
intensity of target proteins in the nucleus compared to the average intensity of target proteins in the 
cytoplasm was larger than 1.  
Mitochondrial morphology was quantified in cells stained with MitoTracker Deep Red using 
Image Pro Plus® software (Media Cybernetics, Rockville, MD, USA) and an algorithm described 
in detail previously [30]. In brief, microscopy images were converted to 8-bit grayscale and 
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background-corrected to obtain a COR image. The COR image was contrast-optimized using a 
linear contrast stretch (LCS) operation. Next, the LCS image was subsequently processed using a 
top-hat filter (THF) and median filter (MED). Then, the MED image was thresholded to obtain a 
binary (BIN) image, representing mitochondrial objects in white on a back background. Finally 
applying a Boolean AND operation on the COR and BIN image yielded a masked (MSK) image, 
in which mitochondrial area (Am; in pixels; a measure of mitochondrial size) and form factor (F; a 
combined measure of mitochondrial length and degree of branching) were quantified. 
Mitochondrial morphology measurements were carried out in 3 independent experiments in each 
of which >25 cells were analyzed.  
Statistical analysis. Statistical analysis was performed with Origin 2018 to assess the significance 
between data. One-way ANOVA tests was applied to compare data between multiple groups with 
a Tukey post-test and Student’s t-test was used for two variables. Significant differences are 
indicated by * P < 0.05 or **P < 0.01. NS indicates no significant difference (P > 0.05). All results 
are presented as mean ± standard error. All experiments were performed at least three independent 
experiments or biological replicates. The number of independent experiments (N) and the number 
of data points (n) in each experiment are indicated within corresponding figure legends. 
Data availability. The authors declare that the data is presented within the paper and its 
Supplementary Information or will be made available by the corresponding author upon 
reasonable request. 
 
3. Results  
3.1 Feedback between spreading and intracellular energy expenditure 
We first determined the influence of substrate stiffness on indicators of energy expenditure such as 
intracellular ATP levels and glucose uptake rates. We cultured hMSCs on 1 kPa (soft) or 20 kPa 
(stiff) polyacrylamide (PAAm) gels functionalized with collagen (50 µg/mL), and determined 
intracellular ATP levels at different time points, from initial adhesion and spreading of cells to 
steady state (when no further morphological changes were observed) (Figure 1a and 
Supplementary Figure 1a, b). Unless noted, cells were always seeded at low density (1250 
cells/cm2) to avoid contributions form cell-cell interactions. Consistent with previous findings [1, 
5], cells grown on stiff substrates displayed larger cell spreading areas with reinforced F-actin 
stress fibers and accompanying lower levels of G-actin, and greater sizes and numbers of FAs (as 
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determined by Vinculin staining) (Supplementary Figure 1c-e). During the same 3 h time 
window after seeding, intracellular ATP levels on the stiff substrate decreased by ~27% (Figure 
1a), consistent with increased energy expenditure for spreading cells and concomitant formation 
of actin cytoskeleton and FAs. At steady state (no further changes in spreading area after 20 h), 
intracellular ATP levels on stiff substrates recovered and even exceeded those on soft ones 
(Figure 1a). Similarly, mouse embryonic fibroblasts (MEF) and NIH 3T3 cells also displayed 
increased intracellular ATP levels when cultured for 20 h on substrates of increasing stiffness 
(Figure 1b). As glucose is the primary source of cellular energy production in hMSCs [31], we 
examined if different substrate mechanics result in changes in glucose uptake. We observed a 31% 
increase in glucose uptake in hMSCs cultured on 20 kPa compared to 1 kPa PAAm substrates as 
demonstrated by the higher intracellular levels of 2-NBDG, a fluorescent glucose analog used for 
monitoring glucose uptake into living cells (Figure 1c). A correlation between energy demand and 
spreading was also evident in glucose starvation experiments. Reducing glucose concentration in 
culture medium from 4.5 to 0 g/L for cells on stiff substrates significantly impacted on intracellular 
ATP levels (~34% lower; Figure 1d) and starvation halted cell proliferation (Supplementary 
Figure 2). To investigate the role of energy in more detail, we monitored hMSC spreading on stiff 
substrates in the presence or absence of glucose (Figure 1e and Supplementary Figure 1b, 3). 
Removal of glucose from the culture medium resulted in significantly reduced actin 
polymerization and FA formation, reflected by a 3.8-fold increase in G/F-actin levels (Figure 1f) 
after 20 h culture. We further studied the temporal characteristics of intracellular ATP changes 
upon disruption and re-organization of the actin cytoskeleton. To do this, cells were treated for 1 h 
with Cytochalasin D (CytoD) [8], which disrupts the actin cytoskeleton, and resulted in cells 
displaying a small rounded morphology (Figure 1g). After CytoD removal from the medium, cells 
were allowed to re-spread on the substrate, during which intracellular ATP levels dropped by ~22% 
(Figure 1g), This strongly suggests that the actin cytoskeleton organization consumes a significant 
fraction of intracellular ATP. Both actin polymerization and FA formation lead to increased 
actomyosin activity. To investigate if this activity also impacted on intracellular ATP level, cells 
were cultured on stiff substrates and treated with two inhibitors of actomyosin contractility: 
Rho-associated protein kinase (ROCK) inhibitor (Y-27632) and myosin inhibitor blebbistatin 
(Bleb.) [32]. Instead of the observed drop in ATP levels earlier, treatment with inhibitors resulted 
in stable cellular ATP levels (normalized to the obtained values at 0 h) consistent with a less 
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developed actin cytoskeleton and reduced cell contractility (Figure 1h and Supplementary 
Figure 4). 
 
Figure 1. Intracellular ATP levels respond during cell spreading and adhesion (a) Normalized ATP levels of 
hMSCs cultured on soft (1 kPa) and stiff (20 kPa) PAAm gels over time (n=6 biologically independent samples, 
N=3). Intracellular ATP level at time 0 was measured from cells in suspension (before seeding on PAAm hydrogel) 
(b) ATP levels in different types of cells (hMSCs, MEF, NIH3T3) at 20 h after seeding on PAAm gels (1, 20 and 
100 kPa) (n=6 biologically independent samples, N=3). (c) Glucose uptake on different substrates visualized by 
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2-NBDG (red). Graph: quantification of 2-NBDG intensity (n=5 biologically independent samples, N=3). Scale bars, 
100 µm. (d) Intracellular ATP levels in response to different glucose concentration in the medium (n=6 biologically 
independent samples, N=3). (e) Confocal images of hMSCs cultured in the presence or absence of glucose on stiff 
PAAm gels showing G-actin (stained via labeled DNaseI: green) and FAs (vinculin staining: green) at different time 
points. F-actin was stained with phalloidin (red) and nuclei were counterstained with DAPI (blue). Scale bars, 50 µm 
(left three) and 10 µm (right). (f) Quantification of G/F actin ratio (n>75 cells from three independent experiments), 
FA numbers (n>75 cells from three independent experiments) and normalized ATP levels (n=6 biologically 
independent samples, N=3) in hMSCs cultured under glucose starvation on stiff PAAm gel. (g) Actin disassembly 
with 2.5 µM Cytochalasin D (Cyto D) and actin recovery after removal of Cyto D. Confocal images show the 
changes in cellular morphologies. Graph shows changes in intracellular ATP intensity (n=6 biologically independent 
samples, N=3). Scale bars, 50 µm. (h) Normalized ATP intensity in hMSCs cultured on stiff PAAm gel treated with 
50 µM myosin inhibitor Blebbistatin (Bleb.) or 50 µM Rock inhibitor Y27632 (n=6 biologically independent 
samples, N=3). (i) Quantification of intracellular ATP intensity at 3, 10 and 20 h after 1 h of treatment with Cyto D 
and Bleb.. (n>6 biologically independent samples, N=3). Images of (c, e, g) are representative of at least three 
independent experiments. Data are shown as mean ± s.d., * and ** indicate P values of < 0.05 and <0.01, 
respectively. 
 
As cell spreading is a dynamic process, we wondered if disruption of actin cyctoskeleton 
formation and cell contractility at different time points would lead to different responses. We 
hypothesized that during the early spreading stage, actin polymerization would consume most 
ATP, whereas at steady state (i.e. in fully spread cells), maintaining cell tension would require 
higher energy expenditure than actin polymerization. To validate our hypothesis, we studied the 
relative contributions by inhibiting actin polymerization and cytoskeletal tension using CytoD and 
Bleb., respectively, at different time points (Figure 1i). For ease of comparison, ATP intensities 
were normalized to the non-treated control group at 3 h after seeding. At early time points (3 h), 
inhibition by CytoD restored intracellular ATP levels (up 1.2 fold); whereas Bleb. treatment had 
no significant effect. In contrast, at later time points (10 h and 20 h), treatment with CytoD did not 
lead to increases in ATP levels, but the addition of Bleb. did, showing a 12 % increase. These 
results indicate that during early stages of cell spreading, ATP expenditure due actin 
polymerization is indeed more important that cell tension, whereas at steady state the opposite is 
the case.  
 
3.2 AMPK activation correlates with altered mitochondrial morphologies 
In stem cells, mitochondria are prime generators of ATP [14, 24], these organelles are motile, and 
continuously fuse and divide, a process influenced by mechanical cues [14, 22]. In addition to its 
role in ATP production, mitochondrial morphology has been coupled to the coordination of 
self-renewal vs. differentiation of stem cells [33]. Primed by these findings we next determined 
whether substrate stiffness affected mitochondrial morphology. Visual inspection suggested that, 
on soft substrates, mitochondria display a filamentous structure at both 5 h and 20 h after seeding. 
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In contrast, mitochondrial morphology appeared more fragmented on stiff substrates (Figure 2a 
and Supplementary Figure 5). Quantitative analysis [30] revealed that the mitochondrial area 
(Am, a measure of mitochondrial size) and form factor (F, a combined measure of mitochondrial 
length and degree of branching), were significantly reduced on stiff relative to soft substrates 
(Figure 2b, c). Mitochondria in cells on stiff substrates displayed a stronger staining with the 
fluorescent cation tetramethylrhodamine methyl ester (TMRM), (Supplementary Fig. 6), 
suggesting that the mitochondrial membrane potential of these mitochondria is more negative. 
Finally, time-lapse imaging of mitochondria suggested that the mitochondrial fission process was 
faster on stiff substrates compared to soft substrates. (Supplementary Figure 7 and 
Supplementary Movie).  
 
Figure 2. Changes in mitochondrial morphologies and pAMKP/AMPK ratios correlate with ECM stiffness. (a) 
Mitochondrial morphologies in hMSCs on soft or stiff PAAm gels at 5 or 20 hours after seeding. Mitochondria were 
stained with Mito tracker (green). Arrows refer to the zoomed region. Scale bars, 25 µm (left) and 10 µm (right). (b, 
c) Quantification of (b) mitochondrial area and (c) form factor of the cells shown in (b) (n>25 representative cells 
from three independent experiments). (d) Western blots of AMPK and Thr172-phosphorylated AMPK (pAMPK) 
after 5 or 20 h incubation on different PAAm gels. Graph: Quantification of pAMPK/AMPK ratios. AMPK and 
pAMPK were first normalized to actin (numbers shown on the blot) before determining pAMPK/AMPK ratios. 
Images in (a) are representative of at least three independent experiments. Data are shown as mean ± s.d., * and ** 
indicate P values of < 0.05 and <0.01, respectively. 
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 It has been shown that AMPK mediates mitochondrial fragmentation in response to energy stress 
[24]. In this context, we hypothesized that the observed drop in ATP levels during cell spreading 
would result in a similar energy stress, leading to AMPK activation and induction of a fragmented 
mitochondrial phenotype. Western blot analysis revealed increased pAMPK/AMPK ratios in 
hMSCs cultured for 5 and 20 h on stiff vs. soft substrates (Figure 2d). To gain insight into the 
chain of events during AMPK phosphorylation we performed western blot and immunostaining 
analysis at different time points (Supplementary Figure 8). On stiff substrates, virtually no 
pAMPK was observed during initial cellular adhesion period (0.5 h) (Supplementary Figure 8). 
Cells cultured on these substrates for longer than 1 h displayed elevated pAMPK levels as well as 
nuclear localization. Together, these experiments establish that AMPK phosphorylation is 
preceded by a drop in ATP levels (Figure 1a and Supplementary Figure 8). Furthermore, a 
fragmented mitochondrial phenotype was observed 1 h after seeding (Supplementary Figure 9), 
in agreement with the time point at which increased pAMPK levels were observed. 
 
3.3 AMPK plays a central role in mechanotransduction  
Previous studies [11] have linked energy metabolism to E-Cadherin mechanotransduction as liver 
kinase B1 (LKB1) is recruited to the cadherin adhesion complex and activates AMPK. However, it 
is not known if AMPK plays a similar role in the mechanotransduction response from cell-matrix 
interactions. To further explore the role of AMPK in mechanotransduction, we cultured 
AMPKα1-/- AMPKα2-/- (AMPKα-null) mouse embryonic fibroblasts (MEFs) on soft and stiff 
substrates. These cells displayed a 40-50% lower ATP content that was not affected by stiffness 
(Figure 3a). In Figures 3b, c, a lower glucose uptake was shown in AMPKα-null MEFs on stiff 
substrates, compared to WT MEFs, as determined by 2-NBDG intensity. Interestingly, cell 
morphology of WT and AMPKα-null cells on soft substrates appeared very similar (Figure 3d). In 
contrast, on stiff substrates AMPKα-null cells displayed limited spreading, and a less 
well-developed actin cytoskeleton (as evidenced by the ~2.3-fold higher G/F-actin ratio). Figure 
3e demonstrates reduced actomyosin contractility in AMPKα-null cells on stiff substrates and a 
lower number of FAs. YAP/TAZ is a mechanical regulator that typically shows cytoplasmic or 
nuclear localization regulated by external signals [32, 34]. Stiff substrates and actomyosin tension 
are associated with high levels of nuclear YAP/TAZ [3, 35], and in WT cells we observed nuclear 
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localization in 79±10% cells. Conversely, inhibition of actin polymerization and stress fiber 
formation by silencing AMPK almost halved YAP/TAZ nuclear localization (Figure 3f).  
 
 
 
Figure 3. AMPKα-null cells show strongly reduced mechanoresponse on stiff substrates. (a) Normalized ATP 
levels in WT-MEF and AMPKα-null MEF cultured on 1, 20 and 100 kPa PAAm gels at 20 h after seeding  (n=6 
biologically independent samples, N=3). (b) Quantification of glucose taken up on different substrate (n=5 
biologically independent samples, N=3). The difference in glucose uptake in WT MEF and AMPK-null MEF was 
compared between stiff and soft substrate. (c) Confocal images showing 2-NBDG (red) uptake on stiff substrate. 
Scale bars, 100 µm. (d) WT-MEF and AMPKα-null MEF cultured on stiff substrate demonstrating F-actin (red) and 
G-actin (green) after 20 h culture. Top: scale bar 100 µm; middle: scale bar 25 µm; bottom: scale bar 25 µm. Graph: 
quantification of spreading area and G/F-actin ratio (n>75 cells from three independent experiments). (e) Vinculin 
(middle: green) and Myosin II (right: green) expression in cells cultured on stiff substrate. Scale bar 25, µm. Graph: 
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quantification of FA numbers (n>75 cells from three independent experiments) in cells cultured on stiff substrate. (f) 
YAP/TAZ localization in WT and AMPKα-null cells on stiff substrates. YAP/TAZ (green), F-actin and nuclei were 
counterstained with phalloidin (red) and DAPI (blue). Scale bars, 100 µm. Graph: Quantification of YAP/TAZ 
nuclear localization (n>120 cells from three independent experiments) in single cells on stiff substrate. Images of (c, 
d, e, f) are representative of at least two independent experiments with similar results. Data are shown as mean ± s.d., 
** indicate P values of <0.01. NS indicates no significant difference with P > 0.05. 
 
3.4 Manipulating intracellular AMPK activation alters cellular mechanoresponses 
To further dissect the role of AMPK, we modulated its phosphorylation status using a 
cell-permeable AMPK inhibitor (Compound C) or AMPK activator (A-769662) at different 
concentrations after 30 min of cell spreading on stiff or soft substrates, respectively, and then 
evaluated changes in cellular response after culturing cells for 20h. It was found that increasing 
concentrations of AMPK inhibitor resulted in ~60% lower ATP levels on stiff substrates, while 
addition of AMPK activator on soft substrates led to 20% higher ATP levels (Figure 4a). The 
inhibition or activation of AMPK also impacted on glucose uptake, inducing a small (~13%) 
decrease after inhibition of AMPK on stiff substrates, and a 1.2~fold increase after activating 
AMPK on soft substrates (Figure 4b). Inhibition of AMPK on a stiff substrate induced a shift in 
mitochondrial morphology from a fragmented into a more filamentous phenotype. However, 
activation of AMPK on a soft substrate yielded a fragmented mitochondrial phenotype, previously 
associated with the cells cultured on stiff substrates (Figure 4c and Supplementary Figure 10). 
These experiments support a mechanism in which alterations in mitochondrial morphology are 
evoked by changes in AMPK activity. We next investigated whether inhibition or activation of 
AMPK was sufficient in regulating FA formation, cytoskeletal organization and YAP/TAZ 
localization. Inhibition of AMPK clearly influenced FAs, which appeared smaller and confined to 
the edge of spreading cells (Figure 4d). Furthermore, cytoskeletal organization was less 
developed, with fewer cross-cell stress fibers with increasing concentrations of AMPK inhibitor 
(Figure 4d). YAP/TAZ was increasingly localized in the cytoplasm after inhibition of AMPK 
(nuclear localization declined five-fold at 20 µM inhibitor concentration), while nuclear 
YAP/TAZ localization in cells on soft substrates increased upon AMPK activation (Figure 4d). 
Furthermore, we modulated energy substrate supply by varying the extracellular glucose 
concentration. YAP/TAZ nuclear localization only became pronounced at glucose 
concentrations >2.5 g/L and during glucose starvation YAP/TAZ nuclear localization was as low 
as 21±9% (Supplementary Figure 11). Nuclear YAP/TAZ localization induced by ECM stiffness 
requires stress fibers and cytoskeletal tension which can stretch nuclear pores and promote 
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YAP/TAZ translocation. There is a balance of forces between cell adhesion on the outside and 
myosin II-based contractility on the inside of the cell, and myosin II thus plays an important role 
in controlling the mechanoresponse [36]. Inhibition or activation of AMPK clearly alters myosin 
levels (Figure 4e) and the changes mirror trends in YAP/TAZ localization.  
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Figure 4. AMPK inhibition/activation alters ATP levels and cellular mechanoresponses. (a) ATP levels and (b) 
glucose uptake in hMSCs treated with variable concentrations of AMPK inhibitor (Compound C) on stiff substrate 
or treated with AMPK activator (A-769662) on soft substrates after 20 h culture (n=5 biologically independent 
samples, N=3). (c) Mitochondrial morphologies on stiff (left) or soft (right) substrates with (bottom) or without (top) 
AMPK inhibitor/activator treatment. Scale bars, 20 µm (left) and 10 µm (right). (d) The influence of AMPK 
inhibition/activation on cellular mechanoresponses. Confocal images of FAs (top) and YAP/TAZ localization 
(middle) in cells on stiff substrates treated with AMPK inhibitor, and YAP/TAZ nuclear localization in the presence 
of AMPK activator (bottom). Quantification of number of FAs (n>25 representative cells, N=3) and YAP/TAZ 
nuclear localization (n>120 cells from three independent experiments) in single cells. Scale bars, 50 µm. (e) The 
influence of AMPK inhibition/activation on cell tension. Expression of Myosin II in cells seeded on stiff (top two) 
or soft (bottom two) substrate treated with or without AMPK inhibitor/activator. Graph: quantification of Myosin II 
intensity of the cells (n>20 cells from two independent experiments). Scale bars, 25 µm. Images of (c, d, e) are 
representative of at least two independent experiments with similar results. Data are shown as mean ± s.d., ** 
indicate P values of <0.01. NS indicates no significant difference with P > 0.05. 
 
3.5 AMPK activity influences stem cell differentiation into osteoblasts 
 
Figure 5. AMPK inhibition or activation affects stem cell differentiation. (a, b) Runx2 and alkaline phosphatase 
(ALP) staining showing osteogenic differentiation of hMSCs. Runx2 (green) localization and ALP (bright field) 
expression of the cells treated with (a) AMPK inhibitor on stiff substrates or (b) AMPK activator on soft substrates 
(bottom). Scale bars 20 µm (fluorescence images), 250 µm (bright field images). (c) Quantification of Runx2 
nuclear localization after 1 day (n>30 cells from two independent experiments) and ALP positive cells after 7 days 
(n>6 representative images from two independent experiments) at different conditions. (d) Schematic overview 
showing the link between mechanotransduction and energy homeostasis. Images of (a, b) are representative of at 
least two independent experiments with similar results. Data are shown as mean ± s.d., ** indicate P values of <0.01. 
NS indicates no significant difference with P > 0.05. 
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Finally, we determined how manipulation of AMPK activity impacted on cell fate. Runx2 protein 
is a prominent transcription factor which can be detected in pre-osteoblasts and induces the 
differentiation of MSCs into osteoblasts when translocated into the nucleus of stem cells [37,38]. 
Compound C (10 µM) was added to the medium for cells cultured on stiff substrates and A-769662 
(200 µM) was added to the medium for cells on soft substrates. Relative to standard culture 
conditions, a higher Runx2 nuclear localization was detected under conditions that promote higher 
AMPK activation on stiff substrates (i.e. with no inhibitor present) (Figure 5a) or additional 
AMPK activator on soft substrates (Figure 5b) after 1-day culture.  
Further, hMSCs were seeded on different substrates and cultured in mixed adipogenic/osteogenic 
differentiation medium. After 7-10 days culture time, ALP staining was used to indicate 
osteogenic differentiation and Oil Red O staining was performed for adipogenic differentiation. 
ALP staining showed AMPK inhibition in cells on stiff substrates significantly decreased ALP 
intensity, indicating lower osteogenic differentiation, whereas on soft substrates ALP staining was 
significantly enhanced in the presence of AMPK activator (Figure 5c; here higher cell densities 
were necessary, 25000 cells/cm2 instead of 2500 cell/cm2 on soft substrates, as cell numbers 
otherwise were too low to allow differentiation after extended culture times). The observation that 
AMPK modulation can override the impact of biophysical cues in the case of osteogenic 
differentiation correlates with the notion that such differentiation is typically seen on stiff 
substrates, where cells develop strong stress fibers and high intracellular tension. AMPK 
modulation affects these energy-demanding processes. Interestingly, we did not observe 
statistically relevant differences when studying adipogenic differentiation using Oil Red O 
staining when we either inhibited AMPK on stiff substrates, or activated AMKP on soft substrates 
(Supplementary Figure 12). Adipogenic differentiation is typically favored on soft substrates 
where cells have less pronounced stress fibers and associated energy demands, and this might 
explain why the modulation of AMPK does not lead to significant differences.     
 
4. Discussion  
Adhering and spreading cells form focal adhesions and a network of dynamic actomyosin stress 
fibers that maintains a certain tensional homeostasis adapted to the mechanical properties of the 
ECM [1, 5, 39]. These processes require energy, which raises the question of how cells ensure the 
availability of this energy and whether high energy expenditure limits cellular responses. An 
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elevated ATP : ADP ratio due to F-actin formation [40], cytoskeleton remodelling [41], and 
adhesion mediated contractility [42] has been reported to increase glucose uptake during cell 
migration [43], the relationship between the cell dynamics and increased energy utilization. In 
this study we observed a clear link between mechanotransduction and the energy expenditure 
needed for the formation of well-developed FAs, cytoskeletal reorganization into well-defined 
stress fibers in spread cells, as well as the contractility of the cytoskeleton. Intracellular ATP levels 
are strongly affected by these energetically costly processes. In order to look into details about the 
extent of ATP consumption used for actin polymerization and contractility, we selectively 
inhibited actin polymerization by CytoD and actomyosin by Bleb. and revealed that inhibition of 
actin, but not myosin, restored intracellular ATP levels at early time points. However, at steady 
state (after cell area was at equilibrium, or better: steady state), inhibition of myosin, but not actin, 
restored intracellular ATP levels. Those experiments suggested that cells consume ATP to 
organize cytoskeleton at early times during spreading, to maintain tension at later time points (at 
steady state) and approximately 20% of cellular ATP is consumed by these processes.  
A further link between energy metabolism and development of the actin cytoskeleton is 
highlighted by glucose starvation experiments. In the latter, glucose depletion significantly 
reduces actin polymerization and FAs formation, confirming that cellular mechano-responses 
consume a significant fraction of intracellular ATP. We demonstrate (Figure 1) that cell spreading 
on stiff substrates is associated with an initial drop in ATP levels. This drop activates AMPK, a 
kinase that is triggered by changing AMP/ATP ratios that arise from, for example, starvation, 
hypoxia or cell detachment from the matrix [18-20]. Recent studies also provided other AMPK 
activation pathways in various cell types, including Ca2+ influx [44, 45] or cell-cell forces [11]. 
Here we show that AMPK is activated coinciding with the ATP drop and mitochondrial 
fragmentation (Figure 2). As reported previously, mitochondrial trafficking to the leading edge of 
the cell could support the formation of protrusions and focal adhesions, necessary for cell 
migration and force generation [15, 46, 47]. Here, we showed that mitochondrial morphology was 
highly responsive to AMPK activation which is in full agreement with previous studies [24]. This 
strongly suggests that AMPK activation or inhibition directly affects mitochondrial morphology, 
indicating that changes in mitochondrial morphology were coupled to energy metabolism. Given 
the fact that AMPK plays a central role in the coordination of cell metabolism and function [17], its 
activation likely impacts on nuclear localization of YAP/TAZ. In this context, previous reports 
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demonstrated that AMPK lowers YAP activity via phosphorylation [20], evoking the cytoplasmic 
localization of YAP/TAZ. Conversely, we find that YAP/TAZ is predominantly localized in the 
nucleus (Figure 3f), as typically observed in cells spreading on stiff substrates [3, 32]. It should 
be noted that in our study, cells were seeded at very low density to avoid cell-cell interactions, 
whereas previous work has shown that cell-cell contacts play a role in AMPK activation [11]. 
The main finding of our study is that maintaining a high cellular contractility is regulated 
(indirectly) by AMPK as high ATP levels are necessary to support actin polymerization, focal 
adhesions formation and actomyosin contractility. These processes set up a feedback loop that 
couples into YAP/TAZ localization. We present three different lines of evidence for placing 
YAP/TAZ translocation mechanistically downstream of AMPK activation: i) YAP/TAZ 
increasingly localized in the cytoplasm with declining ATP levels after inhibition of AMPK by 
Compound C treatment (Figure 4d). ii) AMPK activation was altered by changing the glucose 
concentration in the culture medium, and we found that YAP/TAZ nuclear localization only 
became pronounced at glucose concentrations >2.5 g/L, whereas glucose starvation resulted in 
YAP/TAZ nuclear localization as low as 21% (Figure 4d). iii) We found that ATP levels and 
glucose uptake were greatly reduced in a AMPKα-null mouse embryonic fibroblast (MEF) cell 
line, and YAP/TAZ localization in the nucleus on stiff substrates was also significantly reduced 
(by 32%). All these results firmly confirmed that AMPK activation can induce YAP/TAZ nuclear 
localization. We further observed that osteogenic differentiation appears correlated with activation 
or inhibition of AMPK, and not with the substrate stiffness.  
In summary, our findings indicate that AMPK-mediated energy regulation plays an important role 
in the cellular mechanoresponse, as shown schematically in Figure 5d. The mechanoresponse on 
stiff substrates is initiated by cell spreading and the concomitant consumption of ATP to establish 
FAs and remodel the actomyosin network. Soon after initiation of cell spreading (i.e. in the first 
0.5 h) ATP expenditure exceeds production, and the drop in intracellular ATP levels triggers 
activation of AMPK. This is consistent with recent evidence demonstrating that cells adapted their 
metabolic activity to variable mechanical cues through stress fiber formation and F-actin bundling 
[48]. After activation of AMPK, we observe a restoration of ATP levels, and ultimately (after 24h) 
even higher levels than before spreading. At the same time, we observe significant changes in 
mitochondrial morphologies pointing at increased ATP production. We found that upregulation of 
ATP production provides the required energy for further spreading and increased cell tension as 
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the actin cytoskeleton organizes and FAs form, leading to a reinforcing cycle. Those experiments 
suggest that cells consume ATP to polymerize actin at early time points, and to increase cell 
tension at later time points. With the increased cell tension, cells that spread on stiff substrates then 
showed the expected YAP/TAZ nuclear localization and, ultimately, osteogenic differentiation. 
 
5. Conclusions 
Taken together, this work establishes temporal changes in intracellular ATP levels during cell 
spreading as a new mechanistic link between mechanical forces and molecular responses. In this 
sense, energy expenditure couples mechanical cues with cellular metabolism via AMPK activation 
in response to lowered ATP levels. These findings provide an impetus for further studies into the 
mechanisms that guide energy metabolic remodeling in cells with increased energy demands 
during their response to environmental cues. Of particular interest in this context is how the 
remodeled energy metabolism in tumor cells shapes their mechanoresponse to ECM alterations.  
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